Long-term treatment with the dipeptidyl peptidase-4 inhibitor saxagliptin in patients with type 2 diabetes mellitus and renal impairment: a randomised controlled 52-week efficacy and safety study
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Long-term treatment with the dipeptidyl peptidase-4 inhibitor saxagliptin in patients with type 2 diabetes mellitus and renal impairment: a randomised controlled 52-week efficacy and safety study
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
Volume 65, Issue 12, Pages 1230-1239
Publisher
Wiley
Online
2011-10-08
DOI
10.1111/j.1742-1241.2011.02812.x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Multifactorial intervention in Type 2 diabetes: The promise of incretin-based therapies
- (2014) F. Giorgino et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- A Repeated Oral Administration Study of Febuxostat (TMX-67), a Non-Purine-Selective Inhibitor of Xanthine Oxidase, in Patients With Impaired Renal Function in Japan
- (2012) Hosoya Tatsuo et al. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
- Influence of Renal or Hepatic Impairment on the Pharmacokinetics of Saxagliptin
- (2011) David W. Boulton et al. CLINICAL PHARMACOKINETICS
- Initial combination therapy with saxagliptin and metformin provides sustained glycaemic control and is well tolerated for up to 76 weeks
- (2011) A. Pfützner et al. DIABETES OBESITY & METABOLISM
- Saxagliptin improves glycaemic control and is well tolerated in patients with type 2 diabetes mellitus and renal impairment
- (2011) M. Nowicki et al. DIABETES OBESITY & METABOLISM
- Pharmacokinetics and Imaging Properties of Gd-EOB-DTPA in Patients With Hepatic and Renal Impairment
- (2011) Simone Gschwend et al. INVESTIGATIVE RADIOLOGY
- Saxagliptin: A dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes mellitus
- (2010) J. J. Neumiller et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Analysis of Hemodialysis-Associated Hypoglycemia in Patients with Type 2 Diabetes Using a Continuous Glucose Monitoring System
- (2010) Hye Seung Jung et al. Diabetes Technology & Therapeutics
- Inter-Day Glycemic Variability Assessed by Continuous Glucose Monitoring in Insulin-Treated Type 2 Diabetes Patients on Hemodialysis
- (2010) Marco Mirani et al. Diabetes Technology & Therapeutics
- Efficacy and safety of saxagliptin in combination with metformin compared with sitagliptin in combination with metformin in adult patients with type 2 diabetes mellitus
- (2010) André J. Scheen et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Saxagliptin is non-inferior to glipizide in patients with type 2 diabetes mellitus inadequately controlled on metformin alone: a 52-week randomised controlled trial
- (2010) B. Göke et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Liraglutide: effects beyond glycaemic control in diabetes treatment
- (2010) J. B. McGill INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Determinants of Severe Hypoglycemia Complicating Type 2 Diabetes: The Fremantle Diabetes Study
- (2010) Timothy M. E. Davis et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Diagnostic Application of the A1c Assay in Renal Disease
- (2010) A. Sharif et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report
- (2010) Andrew S. Levey et al. KIDNEY INTERNATIONAL
- Saxagliptin: a new DPP-4 inhibitor for the treatment of type 2 diabetes mellitus
- (2009) Abd A. Tahrani et al. ADVANCES IN THERAPY
- Inhibitor selectivity in the clinical application of dipeptidyl peptidase-4 inhibition
- (2009) Mark Kirby et al. CLINICAL SCIENCE
- Effect of saxagliptin monotherapy in treatment-naïve patients with type 2 diabetes
- (2009) J. Rosenstock et al. CURRENT MEDICAL RESEARCH AND OPINION
- The Efficacy and Safety of Saxagliptin When Added to Metformin Therapy in Patients With Inadequately Controlled Type 2 Diabetes With Metformin Alone
- (2009) R. A. DeFronzo et al. DIABETES CARE
- Saxagliptin given in combination with metformin as initial therapy improves glycaemic control in patients with type 2 diabetes compared with either monotherapy: a randomized controlled trial
- (2009) M. Jadzinsky et al. DIABETES OBESITY & METABOLISM
- Saxagliptin added to a submaximal dose of sulphonylurea improves glycaemic control compared with uptitration of sulphonylurea in patients with type 2 diabetes: a randomised controlled trial
- (2009) A. R. Chacra et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Saxagliptin Added to a Thiazolidinedione Improves Glycemic Control in Patients with Type 2 Diabetes and Inadequate Control on Thiazolidinedione Alone
- (2009) Priscilla Hollander et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Diabetic nephropathy: Important pathophysiologic mechanisms
- (2008) G. Soldatos et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
- Importance of glycemic control on the course of glomerular filtration rate in type 2 diabetes with hypertension and microalbuminuria under tight blood pressure control
- (2008) Karl Thomaseth et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now